These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 10029086

  • 1. Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation.
    Sbih-Lammali F, Clausse B, Ardila-Osorio H, Guerry R, Talbot M, Havouis S, Ferradini L, Bosq J, Tursz T, Busson P.
    Cancer Res; 1999 Feb 15; 59(4):924-30. PubMed ID: 10029086
    [Abstract] [Full Text] [Related]

  • 2. Hepatocyte growth factor suppresses tumor cell apoptosis in nasopharyngeal carcinoma by upregulating Bcl-2 protein expression.
    Li-juan B, Bing L, Zhi L, Yang L, Ying-jie L.
    Pathol Res Pract; 2009 Feb 15; 205(12):828-37. PubMed ID: 19625133
    [Abstract] [Full Text] [Related]

  • 3. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW, Papayoti MH, Netto G, Armstrong DT, Ordonez G, Lawson JM, Stone MJ.
    Clin Cancer Res; 2001 Mar 15; 7(3):691-703. PubMed ID: 11297266
    [Abstract] [Full Text] [Related]

  • 4. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
    Preciado MV, Chabay PA, De Matteo EN, Gismondi MI, Rey G, Zubizarreta P.
    Med Pediatr Oncol; 2002 May 15; 38(5):345-8. PubMed ID: 11979459
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of Bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histological type and survival.
    Vera-Sempere FJ, Burgos JS, Botella MS, Morera C.
    Histol Histopathol; 1997 Jan 15; 12(1):9-18. PubMed ID: 9046038
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O'Sullivan B, Bastianutto C, Liu FF.
    Clin Cancer Res; 2006 Oct 01; 12(19):5726-32. PubMed ID: 17020977
    [Abstract] [Full Text] [Related]

  • 7. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J, Kremmer E, Meseda CA, Mackett M, Hahn P, Gulley ML, Brink A, Swinnen LJ, Greenspan J, De Souza Y, Grässer F, Sham J, Ng MH, Arrand JR.
    J Med Virol; 2001 Sep 01; 65(1):105-13. PubMed ID: 11505451
    [Abstract] [Full Text] [Related]

  • 8. Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome.
    Ping L, Ogawa N, Sugai S.
    Arthritis Rheum; 2005 Feb 01; 52(2):573-81. PubMed ID: 15692983
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.
    Arch Virol; 2004 Feb 01; 149(2):289-302. PubMed ID: 14745596
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
    Shao JY, Ernberg I, Biberfeld P, Heiden T, Zeng YX, Hu LF.
    Anticancer Res; 2004 Feb 01; 24(4):2309-18. PubMed ID: 15330177
    [Abstract] [Full Text] [Related]

  • 11. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
    Lima MA, Ferreira MV, Barros MA, Pardini MI, Ferrasi AC, Mota RM, Rabenhorst SH.
    Diagn Mol Pathol; 2008 Jun 01; 17(2):82-9. PubMed ID: 18382371
    [Abstract] [Full Text] [Related]

  • 12. The CD40-induced protection against CD95-mediated apoptosis is associated with a rapid upregulation of anti-apoptotic c-FLIP.
    Eeva J, Ropponen A, Nuutinen U, Eeva ST, Mättö M, Eray M, Pelkonen J.
    Mol Immunol; 2007 Feb 01; 44(6):1230-7. PubMed ID: 16901543
    [Abstract] [Full Text] [Related]

  • 13. Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.
    Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H.
    Oncogene; 2000 Nov 16; 19(48):5477-86. PubMed ID: 11114725
    [Abstract] [Full Text] [Related]

  • 14. Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.
    Agathanggelou A, Niedobitek G, Chen R, Nicholls J, Yin W, Young LS.
    Am J Pathol; 1995 Oct 16; 147(4):1152-60. PubMed ID: 7573360
    [Abstract] [Full Text] [Related]

  • 15. Expression of the DNase encoded by the BGLF5 gene of Epstein-Barr virus in nasopharyngeal carcinoma epithelial cells.
    Sbih-Lammali F, Berger F, Busson P, Ooka T.
    Virology; 1996 Aug 01; 222(1):64-74. PubMed ID: 8806488
    [Abstract] [Full Text] [Related]

  • 16. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas.
    Khabir A, Sellami A, Sakka M, Ghorbel AM, Daoud J, Frikha M, Drira MM, Busson P, Jlidi R.
    Clin Cancer Res; 2000 Oct 01; 6(10):3932-6. PubMed ID: 11051240
    [Abstract] [Full Text] [Related]

  • 17. CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.
    Kater AP, Evers LM, Remmerswaal EB, Jaspers A, Oosterwijk MF, van Lier RA, van Oers MH, Eldering E.
    Br J Haematol; 2004 Nov 01; 127(4):404-15. PubMed ID: 15521917
    [Abstract] [Full Text] [Related]

  • 18. Alteration of cellular mediated cytotoxicity, T cell receptor zeta (TcR zeta) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC) patients: possible clinical relevance.
    Laytragoon-Lewin N, Porwit-MacDonald A, Mellstedt H, Lewin F.
    Anticancer Res; 2000 Nov 01; 20(2B):1093-100. PubMed ID: 10810402
    [Abstract] [Full Text] [Related]

  • 19. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T, Endo K, Ren Q, Wakisaka N, Murono S, Kondo S, Sato H, Furukawa M.
    Auris Nasus Larynx; 2007 Mar 01; 34(1):73-8. PubMed ID: 17129696
    [Abstract] [Full Text] [Related]

  • 20. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
    Klemenc P, Marin J, Soba E, Gale N, Koren S, Strojan P.
    J Med Virol; 2006 Aug 01; 78(8):1083-90. PubMed ID: 16789009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.